Stock Price
10.11
Daily Change
0.88 9.53%
Monthly
18.38%
Yearly
69.21%
Q2 Forecast
9.90

Novavax reported $125.04M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Adma Biologics USD 88.82M 13.19M Dec/2025
Agenus USD 34.2M 4.61M Dec/2025
AstraZeneca USD 12.61B 225M Mar/2026
BioCryst Pharmaceuticals USD 153.05M 4.16M Dec/2025
Cassava Sciences USD -3.96M 1.16M Sep/2025
Geron USD 50.14M 3.44M Mar/2026
GlaxoSmithKline GBP 5.75B 429M Mar/2026
MannKind USD 68.33M 9.98M Mar/2026
Merck USD 10.85B 2.57B Dec/2025
Minerva Neurosciences -4.27M 26.79M Dec/2024
Moderna USD -566M 792M Mar/2026
Novartis USD 10.82B 694M Sep/2025
Novavax USD 125.04M 76.09M Dec/2025
Pfizer USD 11.04B 1.24B Mar/2026
Sanofi EUR 8.45B 1.31B Dec/2025
Sarepta Therapeutics USD 621.34M 577.79M Mar/2026
TG Therapeutics USD 171.41M 16.98M Mar/2026